@doctormongol @Ysterikus @regenzeit2 @ariarzer а вас в гугле забанили, да? и пабмедом не умеете пользоваться тоже? там вагон исследований за 20+ лет https://t.co/vRJWUGl450
Oral Contraceptives and Venous Thromboembolism: Focus on Testing that May Enable Prediction and Assessment of the Risk.
Mentions
Extended reach
Total likes
Video views
Mentions per month
May 2021 – Mar 2024Where it's discussed
-
YouTube3 videos
-
X / Twitter1 posts
AI synopsis
What people are saying
The discussions reflect curiosity and support, with users expressing the importance of better testing for blood clot risks, as seen in comments about genetic factors and the need for ongoing monitoring. Words like 'important' and questions about 'how to improve testing' indicate thoughtful engagement and recognition of the article's potential significance.
Most discussions acknowledge the importance of the article, especially emphasizing the potential for improved testing methods and personalized risk assessment.
The topic attracts high interest from users discussing personalized medicine and the relevance of genetic screening.
Posts include personal opinions and questions, showing moderate engagement with some depth, such as questioning the feasibility of current testing methods.
Discussions imply the article could influence future research directions and testing protocols, suggesting a moderate to high impact.
Abstract in brief
- Oral contraceptives (COCs) impact blood clotting by increasing procoagulant factors and decreasing anticoagulant factors, especially with newer generations of pills, which boosts the risk of blood clots.
- The risk of venous thromboembolism (VTE) from COCs is higher when combined with other genetic or environmental risk factors, making testing important not only before starting COCs but also during use to monitor clot risk.
- Genetic factors like factor V Leiden and mutations in blood group or specific genes are linked to higher VTE risk, but current genetic screening cannot fully predict who will develop blood clots; tests like the endogenous thrombin potential-based activated protein C resistance are being explored to better assess thrombogenicity.]
Top posts
Most liked on X and BlueskyAll mentions
Understanding Thrombin Generation and Its Clinical Significance
This episode explains thrombin generation, its measurement, and standardization efforts. Presented by Audrey Carlo, Ccile Hourquet, and special guest Marisa Ninivaggi from Synapse Research Institute, focusing on the…
Understanding Thrombin Generation in Hemostasis and Coagulation Analysis
Presented by Audrey Carlo and Ccile Hourquet, this episode features Xavier Teuma discussing what thrombin generation is. Thrombin generation assays are essential for evaluating the hemostatic system and their…
???????? S2E8 - Le risque thrombotique associé à la prise de traitements hormonaux
@doctormongol @Ysterikus @regenzeit2 @ariarzer а вас в гугле забанили, да? и пабмедом не умеете пользоваться тоже? там вагон исследований за 20+ лет https://t.co/vRJWUGl450